Worldwide, one in twelve people is living with viral hepatitis -- a disease that threatens the health of millions of Americans and people across the globe.
WHITEHOUSE: Presidential Proclamation -- World Hepatitis Day, 2012
Hepatitis -- the most common types being hepatitis A, B and C -- refers to inflammation or viral infections of one's liver.
He said hepatitis A was a "short-term infection that has very unpleasant symptoms but is rarely serious".
Second, Bristol-Myers Squibb stopped a Phase II study of its BMS-094 for hepatitis C because of a serious safety issue.
That's distinct from another common form of the disease, hepatitis A, which takes a fecal-oral route via food or household objects.
Hepatitis C has been described as an "approaching epidemic" - and unlike hepatitis A and B, there is no vaccine against it.
The type of cancer in which T67 is being tested is often caused by a hepatitis-C infection, which is much more common in Asia.
Schering-Plough faces legal investigations into its disclosure and pricing practices, a dismal relationship with the Food and Drug Administration and cutthroat competition on its best-selling drug, a treatment for hepatitis C called Peg-Intron.
Among the hits: a Hepatitis B vaccine, a treatment for inter-cranial aneurysms and a bovine growth hormone.
You'll need to have a skin test for tuberculosis, a chest X-ray and a test for hepatitis B before taking infliximab.
Hepatitis A causes flu-like symptoms and anyone concerned should contact their GP, said Public Health Wales.
Some doctors had reported positive results using ribavirin, an anti-viral medicine used mostly against hepatitis C, as a treatment for SARS patients who had been worst-hit by the disease in Hong Kong and elsewhere.
"But a lot of other diseases which do exist in the area are real, " he said, such as hepatitis A and other vaccine-preventable diseases.
Basel, Switzerland-based Roche has started a price war between its hepatitis C drug, Pegasys, and Schering-Plough's Peg-Intron.
More bad news: Mid-stage trials of a new drug for hepatitis C being developed by Wyeth and biotech Viropharma (nasdaq: VPHM - news - people ) were stopped.
The hepatitis A virus can survive in sea water for a number of weeks - meaning these people could contract the disease if the local sea water has been contaminated.
New York (CNN) -- More than 200 people received hepatitis A vaccinations over the weekend after learning that a Manhattan restaurant employee handling sweets was infected with the virus, according to the New York City Department of Health and Mental Hygiene.
Doctors told her she could never take interferon again-a big problem because the main hepatitis C regimens all use this protein.
Tragically, complications resulting from viral hepatitis claim thousands of American lives every year -- a burden borne disproportionately by African American, Hispanic, and Asian American and Pacific Islander (AAPI) communities, and by persons born between 1945 and 1965.
WHITEHOUSE: Presidential Proclamation -- World Hepatitis Day, 2012
More bad news: Mid-stage trials of a new drug for hepatitis C being developed by Wyeth and biotech Viropharma were stopped.
Aside from the loss of its prescription allergy franchise, Schering is facing erosion in its top-selling hepatitis C drugs due to the entry of a new competitor from Roche .
Public awareness remains a critical factor in the prevention, detection and management of this disease and that there is a need to expand knowledge and eliminate hepatitis-related stigma among health care providers, at-risk populations, and the general public.
Last summer sales of Schering-Plough's only other big seller, the hepatitis drug Peg-Intron, nose-dived as doctors switched to a new and more convenient compound from Roche Holding.
Its main product will be an antiviral drug called ribavirin, which is being marketed by Schering-Plough (nyse: SGP - news - people) as part of a combination therapy for hepatitis C.
Cirrhosis caused by chronic hepatitis C or long-term alcohol abuse are the most common reasons for needing a liver transplant.
The infection risks are compounded given that Harrington told investigators he had a higher-than-normal population proportionally of HIV and hepatitis patients, Rogers said.
Its hepatitis C medicines, Rebetol and Peg-Intron, are facing tough competition from a new entrant from Roche , a Basel, Switzerland-based drug giant.
Bristol-Meyers Squibb has been working with ZymoGenetics to also develop a potential hepatitis C treatment.
Biotech firms ZymoGenetics and Idenix saw double-digit gains as a result of increasing interest in their treatments for hepatitis C.
But by mid-June, Pluzhnikov was in a coma, reportedly from "toxic hepatitis, " sparking eerie flashbacks to last fall's "illness" of now President Victor Yushchenko.
应用推荐